Literature DB >> 24824860

A hydrophobic domain within the small capsid protein of Kaposi's sarcoma-associated herpesvirus is required for assembly.

Christopher M Capuano1, Peter Grzesik1, Dale Kreitler1, Erin N Pryce2, Keshal V Desai1, Gavin Coombs2, J Michael McCaffery2, Prashant J Desai1.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) capsids can be produced in insect cells using recombinant baculoviruses for protein expression. All six capsid proteins are required for this process to occur and, unlike for alphaherpesviruses, the small capsid protein (SCP) ORF65 is essential for this process. This protein decorates the capsid shell by virtue of its interaction with the capsomeres. In this study, we have explored the SCP interaction with the major capsid protein (MCP) using GFP fusions. The assembly site within the nucleus of infected cells was visualized by light microscopy using fluorescence produced by the SCP-GFP polypeptide, and the relocalization of the SCP to these sites was evident only when the MCP and the scaffold protein were also present - indicative of an interaction between these proteins that ensures delivery of the SCP to assembly sites. Biochemical assays demonstrated a physical interaction between the SCP and MCP, and also between this complex and the scaffold protein. Self-assembly of capsids with the SCP-GFP polypeptide was evident. Potentially, this result can be used to engineer fluorescent KSHV particles. A similar SCP-His6 polypeptide was used to purify capsids from infected cell lysates using immobilized affinity chromatography and to directly label this protein in capsids using chemically derivatized gold particles. Additional studies with SCP-GFP polypeptide truncation mutants identified a domain residing between aa 50 and 60 of ORF65 that was required for the relocalization of SCP-GFP to nuclear assembly sites. Substitution of residues in this region and specifically at residue 54 with a polar amino acid (lysine) disrupted or abolished this localization as well as capsid assembly, whereas substitution with non-polar residues did not affect the interaction. Thus, this study identified a small conserved hydrophobic domain that is important for the SCP-MCP interaction.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24824860      PMCID: PMC4103069          DOI: 10.1099/vir.0.064303-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  53 in total

1.  Capsid assembly and DNA packaging in herpes simplex virus.

Authors: 
Journal:  Rev Med Virol       Date:  1997-07       Impact factor: 6.989

2.  The pattern of tegument-capsid interaction in the herpes simplex virus type 1 virion is not influenced by the small hexon-associated protein VP26.

Authors:  D H Chen; J Jakana; D McNab; J Mitchell; Z H Zhou; M Dougherty; W Chiu; F J Rixon
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Residues of VP26 of herpes simplex virus type 1 that are required for its interaction with capsids.

Authors:  Prashant Desai; Jean-Claude Akpa; Stanley Person
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Conventional and immunoelectron microscopy of mitochondria.

Authors:  Edward M Perkins; J Michael McCaffery
Journal:  Methods Mol Biol       Date:  2007

5.  Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells.

Authors:  Shou-Jiang Gao; Jian-Hong Deng; Fu-Chun Zhou
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid.

Authors:  P Desai; S Person
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Assembly of the herpes simplex virus capsid: preformed triplexes bind to the nascent capsid.

Authors:  J V Spencer; W W Newcomb; D R Thomsen; F L Homa; J C Brown
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Hexon-only binding of VP26 reflects differences between the hexon and penton conformations of VP5, the major capsid protein of herpes simplex virus.

Authors:  P T Wingfield; S J Stahl; D R Thomsen; F L Homa; F P Booy; B L Trus; A C Steven
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

9.  The assembly domain of the small capsid protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Dale Kreitler; Christopher M Capuano; Brandon W Henson; Erin N Pryce; Daniel Anacker; J Michael McCaffery; Prashant J Desai
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

10.  Three-dimensional localization of pORF65 in Kaposi's sarcoma-associated herpesvirus capsid.

Authors:  Pierrette Lo; Xuekui Yu; Ivo Atanasov; Bala Chandran; Z Hong Zhou
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more
  4 in total

1.  CryoEM and mutagenesis reveal that the smallest capsid protein cements and stabilizes Kaposi's sarcoma-associated herpesvirus capsid.

Authors:  Xinghong Dai; Danyang Gong; Yuchen Xiao; Ting-Ting Wu; Ren Sun; Z Hong Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

2.  Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.

Authors:  Wen-Hung Wang; Chung-Wen Kuo; Li-Kwan Chang; Chen-Chia Hung; Tzu-Hsuan Chang; Shih-Tung Liu
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

3.  Incorporation of the Kaposi's sarcoma-associated herpesvirus capsid vertex-specific component (CVSC) into self-assembled capsids.

Authors:  Peter Grzesik; Derek MacMath; Brandon Henson; Sanjana Prasad; Poorval Joshi; Prashant J Desai
Journal:  Virus Res       Date:  2017-04-26       Impact factor: 3.303

4.  Assembly of infectious Kaposi's sarcoma-associated herpesvirus progeny requires formation of a pORF19 pentamer.

Authors:  Peter Naniima; Eleonora Naimo; Sandra Koch; Ute Curth; Khaled R Alkharsah; Luisa J Ströh; Anne Binz; Jan-Marc Beneke; Benjamin Vollmer; Heike Böning; Eva Maria Borst; Prashant Desai; Jens Bohne; Martin Messerle; Rudolf Bauerfeind; Pierre Legrand; Beate Sodeik; Thomas F Schulz; Thomas Krey
Journal:  PLoS Biol       Date:  2021-11-04       Impact factor: 8.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.